Just In
- 1 hr ago Belgian Man Cleared Of Drunk Driving Because His Body Produces Alcohol Due To A Rare Condition
- 1 hr ago Amitabh Bachchan's Youthful Avatar In Kalki 2898 AD Is Impressive, Check Actors Who Sported Digital De-Aging!
- 2 hrs ago Full Moon In Scorpio In April 2024: How It Will Affect 12 Zodiac Signs
- 2 hrs ago Why You Should Soak Mangoes In Water Before Consuming Them, This Small Step Comes With Big Rewards!
Don't Miss
- Movies Rathnam Advance Booking Update: Vishal And Hari's Romantic Action Film Faces Slow Start
- Technology COLORFUL EVOL P15 Series Gaming Laptops Launched in India: Check Price, Specifications
- News Bengaluru On Dry Days Alert: Liquor Shops Closed For 3 Days Starting Today
- Automobiles Mahindra Bolero Neo Achieves 1-Star Safety Rating At Global NCAP – Automaker Responds
- Education MBSE HSLC Result 2024: How and Where to Check the 10th Class Results
- Sports DC vs GT Dream11 Prediction IPL 2024 Match 40: Squads, Fantasy Tips & Best Picks
- Finance JNK India IPO: Retail Investors Lead With Subscriptions On Day 2; GMP Hints Premium Listing; Check Status
- Travel Fly in Luxury: 10 Ways to Get Free Flight Upgrades
Omicron Reportedly Has 30+ Mutations In Spike Protein Region, May Bypass Vaccines: AIIMS Chief Randeep Guleria
The new Omicron variant of coronavirus has reportedly got over 30 mutations in the spike protein region giving it the potential to develop an immune escape mechanism, and thus the efficacy of vaccines against it needs to be evaluated critically, AIIMS chief Dr Randeep Guelria has said.
The presence of spike protein facilitates a virus' entry into the host cell and is responsible for making it transmissible and causing infection.
"The new variant of coronavirus reportedly has got more than 30 mutations at the spike protein region and therefore has the potential of developing immunoescape mechanisms. As most vaccines (work by) forming antibodies against the spike protein, so many mutations at the spike protein region may lead to a decreased efficacy of COVID-19 vaccines," AIIMS Director Dr Randeep Guelria told PTI.
In such a scenario, the efficacy of vaccines including those in use in India needs to be evaluated "critically", he said. The future course of action will depend on what more data on its transmissibility, virulence and immunoescpae shows, he said.
The Indian SARS-CoV-2 Genomic Consortia INSACOG is closely tracking the new variant of COVID-19 called B.1.1.529 and its presence has not been detected yet in the country, officials have said.
Dr Guleria emphasised the need to be very vigilant and have aggressive surveillance both for international travellers and in the region where there is a sudden increase in the number of cases.
"Also, we must ask everyone to religiously follow Coivd-appropriate behaviour and not let their guards down. Also, it has to be ensured that people get both the doses of vaccine and those who have not yet taken the jab are encouraged to come forward to take it," he said.
The new, and potentially more contagious variant, was first reported to the World Health Organization (WHO) from South Africa on November 24. It has since been identified in Botswana, Belgium, Hong Kong and Israel among other countries.
On Friday, it was designated a Variant of Concern' by the WHO, which named it Omicron. A Variant of Concern' is the WHO's top category of worrying Covid-19 strain.
The Centre on Thursday asked all states and union territories to conduct rigorous screening and testing of all international travellers coming from or transiting through South Africa, Hong Kong and Botswana.
In a letter to the additional chief secretary/principal secretary/secretary (Health) of all states and union territories, Union Health Secretary Rajesh Bhushan asked them to ensure that samples of travellers turning positive are sent to the designated genome sequencing laboratories promptly.
- disorders cureIndia May See A Covid Surge In January, Next 40 Days Crucial; Here Is How To Protect Yourself From COVID-19
- disorders cureCOVID Can Trigger Parkinson's Disease: Study
- disorders cureCommon COVID Symptoms In Fully Vaccinated Individuals: What You Should Know
- wellnessMild COVID Linked To Life-Threatening Blood Clots, Increased Risk Of Cardiovascular Disease; Study
- wellnessCOVID-19 Variants In India: New COVID Variant May Pose Threat To Elderly People
- basicsCovid-19 Linked To Early Onset Of Periods: What You Need To Know
- wellnessCOVID XBB Variants Of Omicron In India: What You Should Know
- disorders cureNew Omicron Subvariant BQ.1 Detected In Maharashtra: What You Should Know
- disorders cureOmicron BF.7 In India, Risk Of Fresh Wave During Diwali: What You Should Know
- womenPriyanka Chopra Speaks On Climate Change, COVID, Poverty At The UN Sustainable Development Goals 2022 Moment
- wellnessCoronavirus Residues Might Be Causing Long COVID: New Study
- art cultureRenowned Spanish Author Javier Marias Passes Away Due To Lung Infection Post COVID-19